Janus Henderson Group
AVIR icon

Janus Henderson Group’s Atea Pharmaceuticals AVIR Stock Holding History

Janus Henderson Group’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-35,909
Closed -$120K – 2601
2023
Q1 		$120K Buy
35,909
+17,769
+98% +$59.3K ﹤0.01% 2597
2022
Q4 		$87.2K Sell
18,140
-18,138
-50% -$87.2K ﹤0.01% 2357
2022
Q3 		$208K Buy
+36,278
New +$208K ﹤0.01% 2390